skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
09/02/1986
Application #:
06684303
Filing Dt:
12/20/1984
Inventors:
MALON KIT, SAUL KIT
Title:
VACCINES FOR PSEUDORABIES DISEASE AND METHODS FOR USE OF SAME
Assignment: 1
Reel/Frame:
004742/0370Recorded: 07/27/1987Pages: 2
Conveyance:
SAID ASSIGNOR HERBY ASSIGN TRANSFER RELEASE AND QUITCLAIM UNTO SAID ASSIGNEE ALL INTEREST IN SAID PATENTS. SEE DOCUMENTS FOR DETAILS
Assignor:
Exec Dt:
07/13/1987
Assignee:
P.O. BOX 270275
HOUSTON, TEXAS 77277
Correspondent:
SUGHRUE, MION, ZINN, MACPEAK & SEAS
1776 K STREET, N.W.
WASHINGTON, D.C. 20006
Assignment: 2
Reel/Frame:
008040/0180Recorded: 04/15/1996Pages: 20
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/20/1994
Assignee:
THE EXTRAMURAL INVENTIONS OFFICE, MSC 7750
6701 ROCKLEDGE DRIVE, ROOM 3188
BETHESDA, MARYLAND 20892
Correspondent:
THE NATIONAL INSTITUTES OF HEALTH
AMY MARIE SNELL
THE EXTRAMURAL INVENTIONS OFFICE
6701 ROCKLEDGE DRIVE, RM 3188, MSC 7750
BETHESDA, MD 20892-7750
Assignment: 3
Reel/Frame:
020863/0714Recorded: 04/28/2008Pages: 3
Conveyance:
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE
Assignor:
Exec Dt:
12/20/1994
Assignee:
NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR)
6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980
BETHESDA, MARYLAND 20892-7980
Correspondent:
DIRECTOR, DEITR
NIH, 6705 ROCKLEDGE DRIVE, SUITE 310
MSC 7980
BETHESDA, MD 20892-7980

Search Results as of: 03/29/2024 10:06 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT